XML 11 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 112,501 $ 150,279
Marketable securities available-for-sale 623,111 592,023
Accounts receivables, net of allowance for doubtful accounts of $12,313 at June 30, 2024 and December 31, 2023, respectively. 61,654 40,607
Other receivables 976 3,926
Inventories, net 62,462 53,290
Prepaid expenses and other current assets 21,308 18,995
Total current assets 882,012 859,120
Property and equipment, net 36,105 37,297
Operating lease right-of-use assets 22,526 24,287
Goodwill 2,007 2,067
Other assets 73,671 74,325
Total assets 1,016,321 997,096
Current liabilities:    
Accounts payable 4,555 5,245
Accrued research and development 4,581 2,982
Accrued liabilities 48,488 49,448
Other current liabilities 4,568 4,520
current liabilities 62,192 62,195
Convertible Notes, net of debt discount of $2,228 and $2,802 at June 30, 2024 and December 31, 2023, respectively (Note 7) 223,272 222,698
Long-term portion of lease liabilities 27,473 29,720
CEPI accrual long-term (Note 6) 60,337 60,337
Other long-term liabilities 198 74
Total liabilities 373,472 375,024
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Common stock: $0.001 par value; 278,000 shares authorized at June 30, 2024 and December 31, 2023; 130,984 shares and 129,530 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 131 130
Preferred stock: $0.001 par value; 5,000 shares authorized atJune 30, 2024 and December 31, 2023; zero shares outstanding at June 30, 2024 and December 31, 2023, respectively 0 0
Additional paid-in capital 1,575,548 1,554,634
Accumulated other comprehensive (loss) gain (4,911) (2,108)
Accumulated deficit (927,919) (930,584)
Total stockholders’ equity 642,849 622,072
Total liabilities and stockholders’ equity $ 1,016,321 $ 997,096